BRIEF-WPD Pharmaceuticals Announces Amended Sublicense Agreement With Moleculin Biotech For Wp1066, Wp1122 And Annamycin Drug Candidates
- ByReuters-
March 30 (Reuters) - WPD Pharmaceuticals Inc WBIO.CD :* WPD PHARMACEUTICALS ANNOUNCES AMENDED SUBLICENSE AGREEMENT WITH MOLECULIN BIOTECH FOR WP1066, WP1122 AND ANNAMYCIN DRUG...